^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    HCCBloodTest

    Company:
    Epigenomics
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    3years
    Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study. (PubMed, BMC Gastroenterol)
    P=N/A | "Methylation biomarkers in cell free plasma DNA provide a new alternative for HCC surveillance. Multiomic panels comprising DNA methylation markers with other biological markers, such as AFP, provide an option to further increase the overall clinical performance of surveillance via minimally invasive blood samples."
    Journal • Clinical
    |
    AFP (Alpha-fetoprotein)
    |
    HCCBloodTest
    4years
    HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) (clinicaltrials.gov)
    P=N/A; N=175; Completed; Sponsor: Epigenomics, Inc; Recruiting --> Completed; Trial completion date: Jul 2019 --> Oct 2019
    Trial completion date • Trial completion
    |
    SEPTIN9 (Septin 9)
    |
    HCCBloodTest